Cargando…
Denosumab-associated Periprosthetic Atypical Femur Fracture: A Case Report
INTRODUCTION: Denosumab is generally used for 5–10 years to treat postmenopausal osteoporosis. Although atypical fractures caused by bisphosphonate use are well known, reports of denosumab-associated femur fractures are rare. CASE REPORT: Herein, a 75-year-old woman suffered an atypical periprosthet...
Autores principales: | Abe, Satomi, Inoue, Masahiro, Mikami, Takashi, Kanno, Taiki, Masuda, Takeshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Indian Orthopaedic Research Group
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10519314/ https://www.ncbi.nlm.nih.gov/pubmed/37753145 http://dx.doi.org/10.13107/jocr.2023.v13.i09.3864 |
Ejemplares similares
-
Atypical fracture of the femur in a patient using denosumab – a case report
por: Schilcher, Jörg, et al.
Publicado: (2014) -
Atypical periprosthetic femur fracture on an underestimated atypical femoral pattern. A case report
por: Caruso, Gaetano, et al.
Publicado: (2021) -
MON-356 Atypical Femur Fracture with Denosumab
por: Mirza, Faryal S, et al.
Publicado: (2020) -
Denosumab and atypical femoral fractures
por: Aspenberg, Per
Publicado: (2014) -
Closed reduction and minimally invasive surgical treatment of type IIIa fragility fractures of the pelvis associated with ipsilateral periprosthetic femur fracture: A case report
por: Yanagisawa, Yohei, et al.
Publicado: (2020)